Cargando…

Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation

RATIONALE: Asthma phenotyping requires novel biomarker discovery. OBJECTIVES: To identify plasma biomarkers associated with asthma phenotypes by application of a new proteomic panel to samples from two well-characterised cohorts of severe (SA) and mild-to-moderate (MMA) asthmatics, COPD subjects and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sparreman Mikus, Maria, Kolmert, Johan, Andersson, Lars I., Östling, Jörgen, Knowles, Richard G., Gómez, Cristina, Ericsson, Magnus, Thörngren, John-Olof, Emami Khoonsari, Payam, Dahlén, Barbro, Kupczyk, Maciej, De Meulder, Bertrand, Auffray, Charles, Bakke, Per S., Beghe, Bianca, Bel, Elisabeth H., Caruso, Massimo, Chanez, Pascal, Chawes, Bo, Fowler, Stephen J., Gaga, Mina, Geiser, Thomas, Gjomarkaj, Mark, Horváth, Ildikó, Howarth, Peter H., Johnston, Sebastian L., Joos, Guy, Krug, Norbert, Montuschi, Paolo, Musial, Jacek, Niżankowska-Mogilnicka, Ewa, Olsson, Henric K., Papi, Alberto, Rabe, Klaus F., Sandström, Thomas, Shaw, Dominick E., Siafakas, Nikolaos M., Uhlén, Mathias, Riley, John H., Bates, Stewart, Middelveld, Roelinde J.M., Wheelock, Craig E., Chung, Kian Fan, Adcock, Ian M., Sterk, Peter J., Djukanovic, Ratko, Nilsson, Peter, Dahlén, Sven-Erik, James, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850689/
https://www.ncbi.nlm.nih.gov/pubmed/34737220
http://dx.doi.org/10.1183/13993003.00142-2021
_version_ 1784652654440349696
author Sparreman Mikus, Maria
Kolmert, Johan
Andersson, Lars I.
Östling, Jörgen
Knowles, Richard G.
Gómez, Cristina
Ericsson, Magnus
Thörngren, John-Olof
Emami Khoonsari, Payam
Dahlén, Barbro
Kupczyk, Maciej
De Meulder, Bertrand
Auffray, Charles
Bakke, Per S.
Beghe, Bianca
Bel, Elisabeth H.
Caruso, Massimo
Chanez, Pascal
Chawes, Bo
Fowler, Stephen J.
Gaga, Mina
Geiser, Thomas
Gjomarkaj, Mark
Horváth, Ildikó
Howarth, Peter H.
Johnston, Sebastian L.
Joos, Guy
Krug, Norbert
Montuschi, Paolo
Musial, Jacek
Niżankowska-Mogilnicka, Ewa
Olsson, Henric K.
Papi, Alberto
Rabe, Klaus F.
Sandström, Thomas
Shaw, Dominick E.
Siafakas, Nikolaos M.
Uhlén, Mathias
Riley, John H.
Bates, Stewart
Middelveld, Roelinde J.M.
Wheelock, Craig E.
Chung, Kian Fan
Adcock, Ian M.
Sterk, Peter J.
Djukanovic, Ratko
Nilsson, Peter
Dahlén, Sven-Erik
James, Anna
author_facet Sparreman Mikus, Maria
Kolmert, Johan
Andersson, Lars I.
Östling, Jörgen
Knowles, Richard G.
Gómez, Cristina
Ericsson, Magnus
Thörngren, John-Olof
Emami Khoonsari, Payam
Dahlén, Barbro
Kupczyk, Maciej
De Meulder, Bertrand
Auffray, Charles
Bakke, Per S.
Beghe, Bianca
Bel, Elisabeth H.
Caruso, Massimo
Chanez, Pascal
Chawes, Bo
Fowler, Stephen J.
Gaga, Mina
Geiser, Thomas
Gjomarkaj, Mark
Horváth, Ildikó
Howarth, Peter H.
Johnston, Sebastian L.
Joos, Guy
Krug, Norbert
Montuschi, Paolo
Musial, Jacek
Niżankowska-Mogilnicka, Ewa
Olsson, Henric K.
Papi, Alberto
Rabe, Klaus F.
Sandström, Thomas
Shaw, Dominick E.
Siafakas, Nikolaos M.
Uhlén, Mathias
Riley, John H.
Bates, Stewart
Middelveld, Roelinde J.M.
Wheelock, Craig E.
Chung, Kian Fan
Adcock, Ian M.
Sterk, Peter J.
Djukanovic, Ratko
Nilsson, Peter
Dahlén, Sven-Erik
James, Anna
author_sort Sparreman Mikus, Maria
collection PubMed
description RATIONALE: Asthma phenotyping requires novel biomarker discovery. OBJECTIVES: To identify plasma biomarkers associated with asthma phenotypes by application of a new proteomic panel to samples from two well-characterised cohorts of severe (SA) and mild-to-moderate (MMA) asthmatics, COPD subjects and healthy controls (HCs). METHODS: An antibody-based array targeting 177 proteins predominantly involved in pathways relevant to inflammation, lipid metabolism, signal transduction and extracellular matrix was applied to plasma from 525 asthmatics and HCs in the U-BIOPRED cohort, and 142 subjects with asthma and COPD from the validation cohort BIOAIR. Effects of oral corticosteroids (OCS) were determined by a 2-week, placebo-controlled OCS trial in BIOAIR, and confirmed by relation to objective OCS measures in U-BIOPRED. RESULTS: In U-BIOPRED, 110 proteins were significantly different, mostly elevated, in SA compared to MMA and HCs. 10 proteins were elevated in SA versus MMA in both U-BIOPRED and BIOAIR (alpha-1-antichymotrypsin, apolipoprotein-E, complement component 9, complement factor I, macrophage inflammatory protein-3, interleukin-6, sphingomyelin phosphodiesterase 3, TNF receptor superfamily member 11a, transforming growth factor-β and glutathione S-transferase). OCS treatment decreased most proteins, yet differences between SA and MMA remained following correction for OCS use. Consensus clustering of U-BIOPRED protein data yielded six clusters associated with asthma control, quality of life, blood neutrophils, high-sensitivity C-reactive protein and body mass index, but not Type-2 inflammatory biomarkers. The mast cell specific enzyme carboxypeptidase A3 was one major contributor to cluster differentiation. CONCLUSIONS: The plasma proteomic panel revealed previously unexplored yet potentially useful Type-2-independent biomarkers and validated several proteins with established involvement in the pathophysiology of SA.
format Online
Article
Text
id pubmed-8850689
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-88506892022-02-18 Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation Sparreman Mikus, Maria Kolmert, Johan Andersson, Lars I. Östling, Jörgen Knowles, Richard G. Gómez, Cristina Ericsson, Magnus Thörngren, John-Olof Emami Khoonsari, Payam Dahlén, Barbro Kupczyk, Maciej De Meulder, Bertrand Auffray, Charles Bakke, Per S. Beghe, Bianca Bel, Elisabeth H. Caruso, Massimo Chanez, Pascal Chawes, Bo Fowler, Stephen J. Gaga, Mina Geiser, Thomas Gjomarkaj, Mark Horváth, Ildikó Howarth, Peter H. Johnston, Sebastian L. Joos, Guy Krug, Norbert Montuschi, Paolo Musial, Jacek Niżankowska-Mogilnicka, Ewa Olsson, Henric K. Papi, Alberto Rabe, Klaus F. Sandström, Thomas Shaw, Dominick E. Siafakas, Nikolaos M. Uhlén, Mathias Riley, John H. Bates, Stewart Middelveld, Roelinde J.M. Wheelock, Craig E. Chung, Kian Fan Adcock, Ian M. Sterk, Peter J. Djukanovic, Ratko Nilsson, Peter Dahlén, Sven-Erik James, Anna Eur Respir J Original Research Articles RATIONALE: Asthma phenotyping requires novel biomarker discovery. OBJECTIVES: To identify plasma biomarkers associated with asthma phenotypes by application of a new proteomic panel to samples from two well-characterised cohorts of severe (SA) and mild-to-moderate (MMA) asthmatics, COPD subjects and healthy controls (HCs). METHODS: An antibody-based array targeting 177 proteins predominantly involved in pathways relevant to inflammation, lipid metabolism, signal transduction and extracellular matrix was applied to plasma from 525 asthmatics and HCs in the U-BIOPRED cohort, and 142 subjects with asthma and COPD from the validation cohort BIOAIR. Effects of oral corticosteroids (OCS) were determined by a 2-week, placebo-controlled OCS trial in BIOAIR, and confirmed by relation to objective OCS measures in U-BIOPRED. RESULTS: In U-BIOPRED, 110 proteins were significantly different, mostly elevated, in SA compared to MMA and HCs. 10 proteins were elevated in SA versus MMA in both U-BIOPRED and BIOAIR (alpha-1-antichymotrypsin, apolipoprotein-E, complement component 9, complement factor I, macrophage inflammatory protein-3, interleukin-6, sphingomyelin phosphodiesterase 3, TNF receptor superfamily member 11a, transforming growth factor-β and glutathione S-transferase). OCS treatment decreased most proteins, yet differences between SA and MMA remained following correction for OCS use. Consensus clustering of U-BIOPRED protein data yielded six clusters associated with asthma control, quality of life, blood neutrophils, high-sensitivity C-reactive protein and body mass index, but not Type-2 inflammatory biomarkers. The mast cell specific enzyme carboxypeptidase A3 was one major contributor to cluster differentiation. CONCLUSIONS: The plasma proteomic panel revealed previously unexplored yet potentially useful Type-2-independent biomarkers and validated several proteins with established involvement in the pathophysiology of SA. European Respiratory Society 2022-02-17 /pmc/articles/PMC8850689/ /pubmed/34737220 http://dx.doi.org/10.1183/13993003.00142-2021 Text en Copyright ©The authors 2022. https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Original Research Articles
Sparreman Mikus, Maria
Kolmert, Johan
Andersson, Lars I.
Östling, Jörgen
Knowles, Richard G.
Gómez, Cristina
Ericsson, Magnus
Thörngren, John-Olof
Emami Khoonsari, Payam
Dahlén, Barbro
Kupczyk, Maciej
De Meulder, Bertrand
Auffray, Charles
Bakke, Per S.
Beghe, Bianca
Bel, Elisabeth H.
Caruso, Massimo
Chanez, Pascal
Chawes, Bo
Fowler, Stephen J.
Gaga, Mina
Geiser, Thomas
Gjomarkaj, Mark
Horváth, Ildikó
Howarth, Peter H.
Johnston, Sebastian L.
Joos, Guy
Krug, Norbert
Montuschi, Paolo
Musial, Jacek
Niżankowska-Mogilnicka, Ewa
Olsson, Henric K.
Papi, Alberto
Rabe, Klaus F.
Sandström, Thomas
Shaw, Dominick E.
Siafakas, Nikolaos M.
Uhlén, Mathias
Riley, John H.
Bates, Stewart
Middelveld, Roelinde J.M.
Wheelock, Craig E.
Chung, Kian Fan
Adcock, Ian M.
Sterk, Peter J.
Djukanovic, Ratko
Nilsson, Peter
Dahlén, Sven-Erik
James, Anna
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
title Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
title_full Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
title_fullStr Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
title_full_unstemmed Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
title_short Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
title_sort plasma proteins elevated in severe asthma despite oral steroid use and unrelated to type-2 inflammation
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850689/
https://www.ncbi.nlm.nih.gov/pubmed/34737220
http://dx.doi.org/10.1183/13993003.00142-2021
work_keys_str_mv AT sparremanmikusmaria plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT kolmertjohan plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT anderssonlarsi plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT ostlingjorgen plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT knowlesrichardg plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT gomezcristina plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT ericssonmagnus plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT thorngrenjohnolof plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT emamikhoonsaripayam plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT dahlenbarbro plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT kupczykmaciej plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT demeulderbertrand plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT auffraycharles plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT bakkepers plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT beghebianca plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT belelisabethh plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT carusomassimo plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT chanezpascal plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT chawesbo plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT fowlerstephenj plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT gagamina plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT geiserthomas plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT gjomarkajmark plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT horvathildiko plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT howarthpeterh plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT johnstonsebastianl plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT joosguy plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT krugnorbert plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT montuschipaolo plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT musialjacek plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT nizankowskamogilnickaewa plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT olssonhenrick plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT papialberto plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT rabeklausf plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT sandstromthomas plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT shawdominicke plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT siafakasnikolaosm plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT uhlenmathias plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT rileyjohnh plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT batesstewart plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT middelveldroelindejm plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT wheelockcraige plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT chungkianfan plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT adcockianm plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT sterkpeterj plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT djukanovicratko plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT nilssonpeter plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT dahlensvenerik plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation
AT jamesanna plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation